Email this article 
Hide
Show all
Original Research
Estimating the burden of cancer in South Africa
Submitted: 23 February 2022 | Published: 11 August 2022
About the author(s)
Emma Finestone, Percept Actuaries and Consultants, Cape Town, South Africa; and, Department of Biostatistics and Epidemiology, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South AfricaJodi Wishnia, Percept Actuaries and Consultants, Cape Town, South Africa; and, Centre for Health Policy, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Abstract
Background: The incidence of cancer is on the rise in South Africa and globally. However, literature on the current and expected future burden of cancer in the country is lacking.
Aim: To develop a model that forecasts the incidence of five of the most commonly diagnosed cancers in South Africa. The model aims to estimate the true underlying burden of cancer, as opposed to diagnosed cases only.
Setting: South Africa.
Methods: Age-specific incidence rates for each cancer are forecasted for the period 2019–2030, based on a combination of public and private sector cohort data. It is assumed that historical trends in changes in the incidence rate of cancer will continue over the forecasting period. Forecasted incidence rates are applied to population forecasts to find the total number of incident cancer cases for the relevant year.
Results: The incidence of all cancers included in this research is increasing over time, with the total number of cases just less than doubling between 2019 and 2030 (from approximately 62 000 to 121 000 incident cases). This is a result of increases in the age-specific incidence rate of cancer, as well as the growth and ageing of the South African population.
Conclusion: Results confirm that cancer is a major and growing public health problem in South Africa. This highlights the need for increases in resources available for cancer services, as well as rapid implementation of cancer prevention strategies, to reduce the number of future cancer cases, and thereby reduce the burden on the health system.
Keywords
Metrics
Total abstract views: 6046Total article views: 17148
Crossref Citations
1. Health and Related Indicators, 2023
Noluthando Ndlovu, Andrew Gray, Ntombifuthi Blose, Matome Mokganya
South African Health Review vol: 26 year: 2024
doi: 10.61473/001c.122768
2. Targeting inflammatory pathways in hepatocellular carcinoma: recent developments
Fulufhelo Tabitha Ramaite, Sanah Malomile Nkadimeng
Discover Oncology vol: 16 issue: 1 year: 2025
doi: 10.1007/s12672-025-03035-8
3. A dynamic scapping workflow for RTK domains: computational modeling of natural products as dual modulators of EGFR and VEGFR signaling in breast cancer
Vincent A. Obakachi, Krishna K. Govender, Penny P. Govender
Molecular Diversity year: 2025
doi: 10.1007/s11030-025-11263-x
4. Knowledge translation and integration of research evidence into practice: A national mandate
John Musonda, Deidre Pretorius, Christiaan Visser, Olufemi Omole
South African Family Practice vol: 67 issue: 1 year: 2025
doi: 10.4102/SAFP.v67i1.6158
5. Navigating the Intricacies of Tumor Heterogeneity: An Insight into Potential Prognostic Breast Cancer Biomarkers
Nastassia Altriche, Simone Gallant, Tanya Nadine Augustine, Kutlwano Rekgopetswe Xulu
Biomarker Insights vol: 19 year: 2024
doi: 10.1177/11772719241256798
6. An electrochemical immunosensor for an alpha-fetoprotein cancer biomarker on a carbon black/palladium hybrid nanoparticles platform
Foluke O. G. Olorundare, Dimpo S. Sipuka, Tsholofelo I. Sebokolodi, Tetsuya Kodama, Omotayo A. Arotiba, Duduzile Nkosi
Analytical Methods vol: 15 issue: 29 first page: 3577 year: 2023
doi: 10.1039/D3AY00702B
7. Buxus natalensis (Oliv.) Hutch (Buxaceae) Exhibits Its Anticancer Potential by Stimulating ROS Production and Caspase-p53-BCL-2-Dependent Apoptosis in Hepatocellular Carcinoma and Prostate Cancer Cell Lines
Emmanuel Mfotie Njoya, Gaetan T. Tabakam, Chika I. Chukwuma, Tshepiso J. Makhafola
International Journal of Molecular Sciences vol: 26 issue: 9 first page: 4173 year: 2025
doi: 10.3390/ijms26094173
8. Gamma gap and albumin-globulin ratio show poor sensitivity for monoclonal gammopathy screening in South Africa
Njabulo Khumalo, Cameron A. Francis, Siphiwe M. Baloyi, Jody A. Rusch
African Journal of Laboratory Medicine vol: 14 issue: 1 year: 2025
doi: 10.4102/ajlm.v14i1.2505
9. Correlation between self-perceived cognitive problems and objective cognitive impairment in non-CNS cancer patients in a resource-constrained health setting in South Africa
Antonio G. Lentoor, Tiro B. Motsamai
Exploration of Neuroscience vol: 4 year: 2025
doi: 10.37349/en.2025.100684
10. A mixed methods protocol for a framework to improve access to radiotherapy services for cancer patients in Gauteng Province, South Africa
Portia N. Ramashia, Pauline B. Nkosi, Sheynaz Bassa, Thokozani P. Mbonane
BMC Health Services Research vol: 25 issue: 1 year: 2025
doi: 10.1186/s12913-025-13130-9
11. Phytochemical Analysis, Antioxidant Activity, and Anticancer Potential of Afzelia quanzensis Welw—Bark Extract: A Traditional Remedy Utilized by Indigenous Communities in KwaZulu-Natal and Eastern Cape Provinces of South Africa
Siphamandla Qhubekani Njabuliso Lamula, Thando Bhanisa, Martha Wium, Juliano Domiraci Paccez, Luiz Fernando Zerbini, Lisa V. Buwa-Komoreng
International Journal of Molecular Sciences vol: 26 issue: 15 first page: 7623 year: 2025
doi: 10.3390/ijms26157623
12. Synthesis and in vitro exploration of the 8-carbo substituted 5-methoxyflavones as anti-breast and anti-lung cancer agents targeting protein kinases (VEGFR-2 & EGFR)
Jackson K. Nkoana, Garland K. More, Malose J. Mphahlele, Ahmed A. Elhenawy
Bioorganic Chemistry vol: 153 first page: 107875 year: 2024
doi: 10.1016/j.bioorg.2024.107875
13. Barriers and enablers to breast cancer screening in rural South Africa
Nelisha Sarmah, Maureen N. Sibiya, Thandokuhle E. Khoza
Curationis vol: 47 issue: 1 year: 2024
doi: 10.4102/curationis.v47i1.2583